Comparison - Aqueous vs. Solvent based Ethylcellulose Films. H.S. Hall, K.D. Lillie & R.E. Pondell

Similar documents
FROM SOLVENT TO AQUEOUS COATINGS. (Out of the Frying Pan...) Ralph E. Pondell. Coating Place, Inc. P.O. Box

Granulation Aggregation

Easy, fast and reliable!

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

METOLOSE: CONTENTS PAGE

Easy, fast and reliable!

REVISION OF MONOGRAPH ON TABLETS. Tablets

TABLET COATING 2. Lec. 9

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

SUMMARY AND CONCLUSION

Hydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems D. Tewari, R. K. Lewis, W. W. Harcum and T Dürig

Folic Acid in Human Nutrition

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ

Dow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

Emulsions. Purpose of emulsions and of emulsification:

ANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section.

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

AnyCoat. From Nature, Beside you.

E S T E R S. Name Physical status at 25 c Application. S h o r t c h a i n a l k y l e s t e r s (c1 - c8)

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

LYCOAT. New solutions for Film Coating from Roquette. LYCOAT for quicker quality coating

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

IMPRESSION MATERIALS

Critical material properties for the design of robust drug products : excipient functionality related characteristics

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS

Evaluation of Moisture Sorption Methods for Aqueous Moisture Barrier Coatings D. Tewari, R. Lewis, B. Kinsey and T. Dürig*

Large scale production

Comparative Evaluation of Enteric Film Coatings Applied in Organic Solvents

Ph. D Synopsis. Mr. Mehul Pravinchandra Patel Page 1

02/09/2016. Roles of Excipients in Pharmaceuticals:

Industrial Pharmacy (3) Solutions as a dosage form. DR.Saad.M.YACOUB

1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small

Table 1 Hydrophilicity of MC and HPMC Grades. Polymer Cloud Point ( C) Hydrophilicity MC HPMC Type 2910 HPMC Type

Improving the Receptivity of PVC Articles Toward WaterBased Inks, Coatings or Adhesives

Challenges and solutions for moisture sensitive API formulation

Formulation Study for Lansoprazole Fast-disintegrating Tablet. II. Effect of Triethyl Citrate on the Quality of the Products

SEMINAR ON PLASTICIZERS NAGARAJU.J

Ion Exchange Resins. Unique Solutions to Formulation Problems

To study the effect that hydroxypropylcellulose (HPC) polymer molecular weight (MW) exerts on drug release rates and mechanism from matrix tablets.

TABLET DESIGN AND FORMULATION

CHAPTER 1 INTRODUCTION

University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester

EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION

KURARAY POVAL & EXCEVAL

SENTRY TM POLYOX Water Soluble Resins

FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels

B. semisolid materials consisting of hydrophilic and hydrophobic portions

Permeability Study on Cellulose Acetate Butyrate Coating Film

The Effects of Antifoams on Ultrafiltration Membranes

Laboratory Pesticide Formulations, Labels, and Safety

International Journal of Innovative Pharmaceutical Sciences and Research

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE

Gellan Gum. Rm.1702, West Unit, No. 41, Donghai Xi Rd, Qingdao, China Post Code:

A matter of timing. ensure optimal delivery for acid-sensitive products. capsugel.com

Table 1. Coating Parameters

Pharmaceutical Preparation For Internal Use

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

ZHONGBAO CHEMICALS CO.,LTD

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

PROCESS OILS FOR RUBBER ITS SELECTION CRITERIA

Speciality additives for PVC

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

CAPMUL + CAPTEX + ACCONON = SEDDS

Physical Pharmacy. Interfacial phenomena. Khalid T Maaroof MSc. Pharmaceutical sciences School of pharmacy Pharmaceutics department

Development of Nutrient Delivery Systems: Ingredients & Challenges

Challenges in Developing Stable and Efficient Probiotic Formulations

Eastman cellulose esters Pharmaceutical applications and drug delivery

Office europeen des brevets. Publication number: Applicant: Chugai Seiyaku Kabushiki Kaisha 5-1, 5-chome, Ukima Kita-ku Tokyo(JP)

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries.

ExcipientFest Americas 2013 SHELLAC. A Versatile Film Coating System

Coatings and Specialty Applications

Edible Films, Coatings & Processing Aids

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

GRAPEVINE DISEASES. Formulation Information & Adjuvants. Online Guide To. Virginia Tech

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39

DRY SYRUPS SWAPNA.M. Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL SEMINAR BY

Design and Characterisation of Sustained Release Microcapsules of Salbutamol Sulphate

The Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation

>>> Oral Formulation Optimization. Introduction. A Tiered Approach for Identifying Enabling Formulations

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

Luwax LG Flakes. Technical Information. Montanic Ester Wax

Pharmaceutical Studies on Formulation and Evaluation of Sustained Release Tablets Containing Certain Drugs

LIFE IS WHEN IT HAS NAFTA

CHAPTER-2 DRUG AND POLYMER PROFILES

LAB.2. Tablet Production Methods

YICK-VIC CHEMICALS & PHARMACEUTICALS (HK) LTD Rm 1006, 10/F, Hewlett Centre, No , Hoi Yuen Road, Kwun Tong, Kowloon, Hong Kong.

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

Enhanced delivery methods for greater efficacy

Re-compaction properties of lactose and microcrystalline cellulose

III. United States Patent (19) Carlsson et al. 11 Patent Number: 5, Date of Patent: Apr. 30, 1996

FORMULATION CHOICE. How and why they are chosen. Dr Andy Fowles On behalf of ECPA Specification Expert Group

COPYRIGHTED MATERIAL. Contents. xiv xv xvi. About the authors Preface Acknowledgments

Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives

SOFT GELATIN CAPSULE. Dr. Nawal Ayash

industrial application

REFERENCES OVERVIEW ADVANTAGES AEROSOLS. Aerosols. and Foams

PHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Experimental Methods

The Function of Emollients in Skin Care

Transcription:

Comparison - Aqueous vs. Solvent based Ethylcellulose Films 80-2 by H.S. Hall, K.D. Lillie & R.E. Pondell Ethylcellulose has a long history of use in the pharmaceutical for coating pharmaceuticals in various forms, including tablets, granules and powders. Reasons for coating pharmaceuticals include taste masking, delayed or sustained release, ease of swallowing, and appearance. Ethylcellulose is used as the primary film former and as a modifier for waxes, glycerides, and other cellulosic resins. While hydroxypropyl cellulose (HPC) and hydroxypropyl methyl cellulose (HPMC) are water-soluble and can be applied as aqueous solutions, (1,2,3,4) commercial ethylcellulose is not water-soluble and to date has been applied form solution in organic solvents. Any preparation involving organic solvents has the potential of releasing solvent vapors into the atmosphere. This is being regulated more and more closely and may require expensive equipment to limit such emissions. Ingestible products prepared using organic solvents must be monitored for residual organic solvent in the product. For some foods tolerances for residual solvents have been established, all other food uses require a Food Additive Petition be filed. Residual solvents are also an area of increasing concern in the pharmaceutical field. Further, organic solvents are rapidly increasing in cost and for this reason it is desirable to limit their use. For encapsulated products the organic solvent may represent 20% to 50 % of the total cost. For all the above reasons it is desirable to formulate without the use of organic solvents when possible. To date this has not been the case for ethylcellulose, however recently as aqueous dispersion of ethylcellulose has become available under the tradename Aquacoat (5). This material, developed at Purdue University by Drs. Banker and Peck, offers the possibility of formulating without the use of organic solvents and this paper is a report of preliminary work using this aqueous ethylcellulose. The material is available under the name Aquacoat as a 30% dispersion (by weight) in water. Surfactants used are not specifically identified but are reported to be GRAS under FDA guidelines. Since an aqueous dispersion of ethylcellulose is clearly different from a solution in organic solvents, it is also clear that the aqueous form should not be used as a direct replacement for organic solutions. We must keep the differences and peculiarities of the aqueous form in mind if we are to realize maximum benefit of this material. While the viscosity of solutions is directly related to the molecular weight of the polymer, the viscosity of dispersions is nearly independent of molecular weight. (6). Since polymer chain length does not contribute to viscosity directly, dispersions can be prepared at higher solids content than 1

polymer solutions without excessive viscosity being encountered. For instance, while solutions of ethylcellulose to 10 cps are seldom used for coating at concentrations above 10% or 12% solids, the aqueous dispersion can be used at 25% to 30% solids. This usually results in a net savings in process time to apply the coating. The reason for this becomes clear when one looks at viscosity curves for solutions of ethylcellulose (7,8), see, Figure 1. Even low molecular weight ethylcellulose typically attains viscosities of 50 to 100 cps at concentrations of 10% to 12% solids by weight. The aqueous dispersion has a viscosity of about 50 cps at 30% solids. While plasticizing the latex can swell the particles and cause an increase in viscosity, it is apparent that the latex can be utilized at relatively high solids content. In solution form the substituted cellulose chains are unraveled and flexible. As the solvent is evaporated the chains knit together in a tangled mass forming a continuous film. Such films are brittle and require a plasticizer to impart useful properties for most applications. In latex form the particles are rigid and the polymer chains are not dispersed or highly flexible, thus they will not fuse into a continuous film unless plasticized. It is necessary that the plasticizer permeate, soften and swell the polymer making it soft enough to fuse into a continuous film when dried. FIGURE 1 2

Latex particles form a film by first forming a closely packed layer of particles surrounded by a film of water (9,10.11). The surface tension of the water film creates great pressure on the particles and the film of water shrinks. The particles must be deformable enough to fuse together under this pressure if a continuous film is to be formed. Hercules literature (8) lists many of the plasticizers, which have been found useful with ethylcellulose films in the past. The latex formulation places constraints on incorporation of the plasticizers, which limits the usefulness of some of these. The plasticizer should not be highly water-soluble since this would cause the plasticizer to remain in the water phase and not soften the latex particles. The plasticizer must also be efficient, that is markedly soften the latex particles so that they may be readily deformed into a continuous film upon drying. Table 1 lists plasticizers commonly used with ethylcellulose. Those marked with a + have been found useful with the latex form, those marked with a - have not been found useful to date, while those not marked have not been evaluated at this time. Table I PHTHALATE ESTERS PHOSPHATE ESTERS Cyclohexyl ethyl phthalate Santicizer 140 Cyclohexyl methyl phthalate Tricresyl Phosphate +Dibutyl phthalate Triethyl phosphate +Diethyl phthalate Tripehenyl phosphate Diisopropyl phthalate Dimethyl phthalate +Dioctyl phthalate OILS Lubricating oil MISCELLANEOUS ESTERS -Mineral oils, refined Acetyl tributyl citrate Caster oil Acetyl triethyl citrate -Corn oil Butyl stearate Cottonseed oil +Dibutyl sebacate -Durkex 500 Dibutyl tartrate Diisobutyl adipate OTHERS +Glycerol Monostearate Oleic acid Pegosperse 100 ml -Stearic acid Methoxyethyl oleate -PEG 4000 Butoxyethyl stearate -PEG 6000 +Triethyl citrate Cetyl alcohol +Tributyl citrate Myristyl alcohol +Tributyrin (glycerol tributyrate) Stearyl alcohol 3

Because the latex has surfactants present, many of the plasticizers found useful with the latex can be incorporated simply by stirring them directly into the latex. If very high levels of plasticizers are to be added, more than 20%, it may be necessary to first form an emulsion of the plasticizer in water. The plasticizer/latex combination should be stirred gently for at least one-hour prior to use to permit the plasticizer to migrate into the latex particles. A typical formulation is given below for plasticized latex at 30% solids. Total Solids Aquacoat (30% solids) 333 g. 100 g. Dibutyl Sebacate 25 g. 25 g. Water 59 g. Our interest in this material is as a coating, which may provide useful properties without the use of organic solvents. One of the first trials involved in the coating of a proprietary drug for sustained release purposes. Samples of the drug, a granular product, were coated with several levels of the latex coating plasticized with diethyl phthalate (DEP). As expected, the release curves show a decreasing rate, Figure 2, of release as the coating level increases. The initial data indicates that the aqueous coating leaches at a faster rate than does an ethylcellulose film applied from methanol/methylene chloride however later work showed that the leach rate for coatings prepared with the latex are sensitive to the plasticizer chosen. The data in figure 2 are for a latex coating plasticized with diethylphthalate (DEP). Figure 3 is a comparison of the release rate for films plasticized with DEP and Tributryn. This data clearly shows that the Tributryn film releases more slowly than the DEP film. While further work is needed, it is believed that this reflects better film formation when DEP is used to plasticize the latex. FIGURE 2 FIGURE 3 4

Dr. S. Jan et. al of Purdue University has reported (12) that a film of Aquacoat plasticized with tributyl citrate (13) applied onto lactose tablets displayed enteric release, that is they did not disintegrate for one hour in simulated gastric fluid but did release when immersed in simulated intestinal fluid. It has been noted that when the tablets disintegrated in intestinal fluid the film did not dissolve, but did fragment and allow the tablets to disintegrate. Efforts to reproduce this work were not successful when placebo tablets containing Avicel were used, but tests with lactose tablets did confirm Jan's results. Since the coating does not dissolve upon disintegration, and since no ph functionality is expected from ethylcellulose films we are unable to adequately explain the release mechanism. The reason that the Avicel cores do not display this behavior seems to be that the rapid swelling associated with the Avicel ruptures the film. Additional light was shed on this phenomenon by some release data provided by another client. We had prepared coated particles using an Aquacoat/DEP composition, which was tested for sustained, released. In one release test the ph of the media was varied with time to simulate the ph progression in the gut. (Figure 4). An apparent increase in release rate was observed when the ph was raised form ph=2.5 to ph=4.5, but this increase was not sustained as the ph rose to 7.0. Release curves were then determined at three different ph's (Figure 5). Although the active is proprietary and cannot be identified here, its solubility does not account for a release maxima at ph's between ph=4.0 and ph=7.0. FIGURE 4 FIGURE 5 5

Another area in, which an aqueous dispersion of ethylcellulose shows promise is as a modifier in water based coatings using water-soluble polymers. As an example, hydroxypropyl methylcellulose (HPMC) is used as a film coating on tablets from aqueous solution. Because of viscosity solution concentrations of 10% or less are usually used. The aqueous ethylcellulose at 30% solids can be added to such solutions with the effect of increasing the solids content while reducing the viscosity. This translates into higher throughput per coating machine. (see Figure 6) In addition, coatings of HPMC, which contain ethylcellulose, are less sensitive to humidity while retaining rapid release properties. This can be particularly important for products distributed in tropical areas. Figure 7 shows percent weight gain for placebo tablets containing dicalcium phosphate and Avicel at 52% and 92 % relative humidity at room temperature. 6

FIGURE 7 An additional benefit of the ethylcellulose dispersion added to HPMC films is a reduced shrinkage of the HPMC film as water is evaporated. When monogrammed tablets are coated with aqueous HPMC a problem, which may arise, is obscuring of the monogram. This is often caused by shrinkage of the HPMC film in drying. As the film shrinks tension causes the film to be pulled up out of the monogram resulting in the film being stretched across the embossed monogram, obscuring it. With reduced shrinkage this problem is largely avoided. One area of concern with all latex formulations concerns the fusing of the film. As mentioned earlier, the water plays as important role in causing the particles to fuse into a continuous film. If the latex is applied onto highly soluble cores, or cores which absorb water very rapidly, the core may compete for the water, interfering with film formation. (9,14) In such cases a hydrophobic precoat may be required. We are currently pursuing such precoatings, which may be applied, from aqueous systems. Initial data indicate that the presence of a precoat between water sensitive cores and the latex coating markedly improve the integrity of the resulting film. We'd like to thank Dr. Dev Mehra of FMC as well as those clients who made data available but asked that their identity be protected for permission to use that data in this report. 7

1) Air Suspension Encapsulation of Moisture Sensitive Particles Using Aqueous Systems; Hall Hinkes; Proceeding ACS Symposium on Microencapsulation; Processes and Applications; August, 1973. 2) Tablet Coating in an Aqueous System; Shin-Etsu Chemical (Biddle Sawyer), 1975. 3) Methocel Cellulose Ethers - Aqueous Systems for Tablet Coating; Dow Chemical; Form 192-622-77; 1977. 4) Film Coating of Solid Dosage Forms - Aqueous Systems; Dr. G.J. Jackson, presented Academy of Pharmaceutical Sciences 15th Annual Eastern Regional Meeting; 1975. 5) FMC Research Update; Aquacoat Application Bulletin; FMC Corporation; 1979 6) Latex Presentation, B.F. Goodrich Chemical Co. Whitlock, et. al.; B.F. Goodrich Chemical Co.; 1969 7) Ethocel Ethylcellulose Resins; Dow Chemical Co. Form 192-662-78, 1978. 8) Ethylcellulose, Properties and Uses; Hercules, Inc.; 63675LP, 1974. 9) Film Forming Characteristics of Emulsion Polymers; Zdanowski & Brown; 44th Mid-Year Meeting Proceedings of the Chemical Specialties Manufactures Association, May 1958. 10) Use of Aqueous Synthetic Polymer Dispersions for Coating Pharmaceutical Dosage Forms; Lehman & Dreher; Drugs Made in Germany; Vol XVI, 1973. 11) Focus - PVDC Coatings; Elschnig, et. al.; Paper, Film, & Foil Converter; October 1968 - March 1969. 12) Development of Enteric Coatings Using Ethylcellulose Latex; Jan, Banker, Peck, unpublished, August 1979. 13) Technical Bulletin No. 31, Citroflex Plasticizers; Pfizer Chemicals Div.; 1976. 14) B. F. Goodrich in-house publication on Latexes, 1969. 8